Stock SIOX SIO GENE THERAPIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Sio Gene Therapies Inc. Nasdaq

Equities

SIOX

US8293991043

Delayed Nasdaq
Other stock markets
 03:58:58 2024-02-07 pm EST 		5-day change 1st Jan Change
0.478 USD +1.70% Intraday chart for Sio Gene Therapies Inc. +22.88% +29.19%
2023 Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from S&P TMI Index CI
2023 Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from NASDAQ Composite Index CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share
GL
Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share
AQ
SIO GENE THERAPIES INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from S&P TMI Index
CI
Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from NASDAQ Composite Index
CI
Sio Gene Therapies : Failure to Satisfy Listing Rule - Form 8-K
PU
SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Sio Gene Therapies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Sio Gene Therapies Board Approves Plan of Liquidation, Dissolution; Shares Rise After Hours
MT
Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution
GL
Sio Gene Therapies : Announces Board Approval of Plan of Complete Liquidation and Dissolution - Form 8-K
PU
SIO GENE THERAPIES INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Sio Gene Therapies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Sio Gene Therapies Announces Fiscal Second Quarter 2022 Financial Results
AQ
Sio Gene Therapies : Failure to Satisfy Listing Rule - Form 8-K
PU
SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
Sio Gene Therapies : Announces Fiscal First Quarter 2022 Financial Results - Form 8-K
PU
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SIOX Stock
  4. SIOX Stock
  5. News Sio Gene Therapies Inc.